1. Home
  2. STEM vs CRBU Comparison

STEM vs CRBU Comparison

Compare STEM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

HOLD

Current Price

$18.96

Market Cap

137.9M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.62

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEM
CRBU
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.9M
203.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
STEM
CRBU
Price
$18.96
$1.62
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$14.60
$8.50
AVG Volume (30 Days)
253.6K
1.1M
Earning Date
03-03-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$164,948,000.00
$9,295,000.00
Revenue This Year
$3.43
$0.22
Revenue Next Year
$12.04
$4.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$0.66
52 Week High
$32.23
$3.54

Technical Indicators

Market Signals
Indicator
STEM
CRBU
Relative Strength Index (RSI) 54.30 48.31
Support Level $17.26 $1.39
Resistance Level $21.05 $1.63
Average True Range (ATR) 1.98 0.09
MACD 0.20 0.00
Stochastic Oscillator 58.13 56.59

Price Performance

Historical Comparison
STEM
CRBU

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: